Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
8.68
+0.79 (10.01%)
At close: Mar 9, 2026, 4:00 PM EDT
8.66
-0.02 (-0.23%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Vanda Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 84.85 | 102.32 | 135.82 | 135.03 | 52.07 | Upgrade
|
| Short-Term Investments | 179 | 272.33 | 252.44 | 331.83 | 380.74 | Upgrade
|
| Cash & Short-Term Investments | 263.85 | 374.64 | 388.26 | 466.86 | 432.81 | Upgrade
|
| Cash Growth | -29.57% | -3.51% | -16.84% | 7.87% | 17.70% | Upgrade
|
| Receivables | 54.58 | 47.1 | 34.16 | 33.51 | 32.47 | Upgrade
|
| Inventory | 1.85 | 1.73 | 1.36 | 1.19 | 1.03 | Upgrade
|
| Prepaid Expenses | 26.88 | 15.42 | 9.17 | 6.23 | 12 | Upgrade
|
| Restricted Cash | 0.1 | - | - | - | - | Upgrade
|
| Other Current Assets | - | - | - | 11.5 | - | Upgrade
|
| Total Current Assets | 347.26 | 438.89 | 432.95 | 519.29 | 478.3 | Upgrade
|
| Property, Plant & Equipment | 13.51 | 12.68 | 9.14 | 10.97 | 12.39 | Upgrade
|
| Other Intangible Assets | 117.09 | 114.1 | 121.37 | 18.57 | 20.08 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 81.44 | 75 | 74.04 | 74.88 | Upgrade
|
| Other Long-Term Assets | 11.08 | 9.1 | 9.99 | 11.38 | 8.15 | Upgrade
|
| Total Assets | 488.95 | 656.2 | 648.44 | 634.25 | 593.79 | Upgrade
|
| Accounts Payable | 4.94 | 3.5 | 7.15 | 12.69 | 0.93 | Upgrade
|
| Accrued Expenses | 47.8 | 31.32 | 28.92 | 30.53 | 31.2 | Upgrade
|
| Current Portion of Leases | 5.56 | 4.27 | 2.4 | 2.33 | 2.31 | Upgrade
|
| Other Current Liabilities | 86.87 | 60.9 | 49.24 | 45.89 | 39.98 | Upgrade
|
| Total Current Liabilities | 145.16 | 99.98 | 87.7 | 91.44 | 74.42 | Upgrade
|
| Long-Term Leases | 7.07 | 8.09 | 7.01 | 8.81 | 10.06 | Upgrade
|
| Other Long-Term Liabilities | 9.53 | 9.59 | 8.83 | 6.8 | 4.39 | Upgrade
|
| Total Liabilities | 161.76 | 117.66 | 103.53 | 107.05 | 88.86 | Upgrade
|
| Common Stock | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | Upgrade
|
| Additional Paid-In Capital | 721.26 | 712.71 | 700.27 | 686.24 | 669.22 | Upgrade
|
| Retained Earnings | -394.77 | -174.29 | -155.39 | -157.9 | -164.18 | Upgrade
|
| Comprehensive Income & Other | 0.63 | 0.07 | -0.03 | -1.19 | -0.18 | Upgrade
|
| Shareholders' Equity | 327.19 | 538.55 | 544.91 | 527.2 | 504.93 | Upgrade
|
| Total Liabilities & Equity | 488.95 | 656.2 | 648.44 | 634.25 | 593.79 | Upgrade
|
| Total Debt | 12.62 | 12.36 | 9.4 | 11.14 | 12.37 | Upgrade
|
| Net Cash (Debt) | 251.23 | 362.28 | 378.86 | 455.72 | 420.45 | Upgrade
|
| Net Cash Growth | -30.65% | -4.38% | -16.86% | 8.39% | 18.73% | Upgrade
|
| Net Cash Per Share | 4.26 | 6.23 | 6.58 | 8.00 | 7.39 | Upgrade
|
| Filing Date Shares Outstanding | 59.11 | 58.32 | 57.54 | 56.79 | 55.91 | Upgrade
|
| Total Common Shares Outstanding | 59.1 | 58.31 | 57.53 | 56.78 | 55.9 | Upgrade
|
| Working Capital | 202.1 | 338.91 | 345.25 | 427.86 | 403.88 | Upgrade
|
| Book Value Per Share | 5.54 | 9.24 | 9.47 | 9.28 | 9.03 | Upgrade
|
| Tangible Book Value | 210.1 | 424.45 | 423.54 | 508.63 | 484.85 | Upgrade
|
| Tangible Book Value Per Share | 3.55 | 7.28 | 7.36 | 8.96 | 8.67 | Upgrade
|
| Machinery | 9.37 | 8.23 | 7.78 | 7.58 | 7.03 | Upgrade
|
| Leasehold Improvements | 5.5 | 5.47 | 5.44 | 5.42 | 5.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.